Vanderbilt University Medical Center, Nashville, TN [email protected]
Dr. Rosas-Salazar reports receiving grants from the National Institutes of Health (NIH), speaking fees from the American Academy of Allergy, Asthma, and Immunology and the American Association for Respiratory Care, and consulting fees from AstraZeneca and the KOL Connection. Dr. Bacharier reports receiving grants from the NIH, receiving consulting and speaking fees from Sanofi/Regeneron Pharmaceuticals, receiving consulting fees from GlaxoSmithKline, Genentech/Novartis, Teva Pharmaceuticals, Boehringer Ingelheim, AstraZeneca, Circassia Pharmaceuticals, Kinaset Therapeutics, and OM Pharma, being a member of a data and safety monitoring board for DBV Technologies and Vertex Pharmaceuticals, receiving fees for the development of continuing medical education programs from WebMD/Medscape, and receiving royalties from Elsevier. Dr. Hartert reports receiving grants from the NIH, receiving fees from the NIH for service on the National Heart, Lung, and Blood Advisory Council, receiving fees from the American Thoracic Society for service on the Vaccine and Immunization Initiative, receiving fees from the Francis Family Foundation for service on the Council of Scientific Advisors, receiving authorship fees from UpToDate, receiving speaking fees from the American Academy of Allergy, Asthma, and Immunology and Sanofi Pasteur, and being a member of a data and safety monitoring board for Pfizer. No other potential conflict of interest relevant to this letter was reported.
